An efficient, commercially viable, and safe process for preparation of losartan potassium, an angiotensin II receptor antagonist

Organic Process Research and Development

Volumn 16, Issue 12, 2012, Pages 2025-2030

  Madasu, Suri Babu ^a,b   Vekariya, N A ^a   Koteswaramma, Ch ^a   Islam, Aminul ^a   Sanasi, Paul Douglas ^b   Korupolu, Raghu Babu ^b  

^a Aurobindo Pharma Ltd   (India)

^b ANDHRA UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; ANTIHYPERTENSIVE DRUGS; LOSARTAN POTASSIUM; RECEPTOR ANTAGONISTS; RECRYSTALLIZATIONS; REGULATORY REQUIREMENTS; SAFE PROCESS;

POTASSIUM;

EID: 84871545731     PISSN: 10836160     EISSN: 1520586X     Source Type: Journal    
DOI: 10.1021/op300179u     Document Type: Article

References (24)

1. Sealy, J. E.; Laraugh, J. H. In Hypertension: Pathaophysiology, Diagnosis and Management; Laraugh, J. H., Brenner, B. M., Eds.; Raven: New York, 1990; p 1287.
2. Valloton, M. B. Trends Pharmacol. Sci. 1987, 8, 69
3. Marsden, P. A.; Brnner, B. M.; Ballermann, B. J. In Hypertension: Pathaophysiology, Diagnosis and Management; Laraugh, J. H.; Brenner, B. M., Eds.; Raven: New York, 1990; p 1247.
4. Ondetti, M. A.; Rubin, B.; Cushman, D. W. Science 1977, 196, 441
5. Patchett, A. A.; Harris, E.; Tristram, E. W.; Wyvratt, M. J.; Wu, M. T.; Taub, D.; Greenlee, W. J.; Lohr, N. S.; Hoffsommer, R. D.; Joshua, H.; Ruyle, W. V.; Rothrock, J. W.; Aster, S. D.; Maycock, A. L.; Robinson, F. M.; Hirschmann, R.; Sweet, C. S.; Ulm, E. H.; Gross, D. M.; Vassil, T. C.; Stone, C. A. Nature 1980, 288, 280
6. Soffer, R. L.; Sen, I. J. Cardiovasc. Pharmacol. 1985, 7, 63
7. Xei, M. H.; Liu, F. Y.; Wong, P. C.; Timmermans, P. B. M. W. M.; Cogan, M. G. Kidney Intl. 1990, 38, 473
8. Duncia, J. V.; Carini, D. J.; Chiu, A. T.; Johnson, A. L.; Prince, W. A.; Wong, P. C.; Wexler, R. R.; Timmermans, P. B. M. W. M. Med. Res. Rev. 1992, 12, 149
9. Karl, F. H.; Johannes, F. E. M. J. Am. Soc. Nephrol. 2002, 13, 1100
10. Veerka, M.; Putala, M.; Brath, H.; Zupancic, S. A Process for the Preparation of Sartan Derivates and Intermediates Useful in Such Process. EP 1,764,365 A, 2007.
11. Robert, D. L.; Anthony, O. K.; Cheng, Y. C.; Edward, G. C.; Bruces, S. F.; Edward, F. R.; Chunhua, Y.; David, R. L.; Robert, A. R.; David, M. T.; Thomas, R. V.; Paul, J. R. J. Org. Chem. 1994, 59, 6391
12. George, B. S.; George, C. D.; David, C. H.; Anthony, O. K.; Thomas, R. V. J. Org. Chem. 1994, 59, 8151
13. Zachary, P. D.; Barry, K. S. J. Org. Chem. 2001, 66, 7945
14. Carini, D. J.; Duncia, J. V.; Paul, E.; Aldrich.; Chiu, A. T.; Johnson, A. L.; Michael, E. Pieru.; Prince, W. A.; Joseph, B. S, III; Gregory, J. Wells.; Wexler, R. R.; Wong, P. C.; Sung-Eun, Yoo.; Timmermans, P. B. M. W. M. J. Med. Chem. 1991, 34, 2525
15. Jang, S. Y.; Kim, S. B.; Yun, S.; Kim, H. K.; Suh, K. H. Method for preparing Losartan. WO/2007/133040, 2007.
16. Ramakrishnan, A.; Bhushhan, V. D.; Dinesh, D. B.; Kundan, S. S. An Improved Process for the Manufacture of Losartan Potassium. WO/2007/119246, 2007.
17. Herr, R. J. Bioorg. Med. Chem. 2002, 10, 3379
18. David, J. C.; John, V. D.; Pancras, C. B. W. U.S. Patent, 5,138,069, 1992.
19. Veera, R. A.; Udaya, B. R. S.; Rajendiran, C.; Jasti, V. An Improved Process for the Preparation of Losartan. WO/2007/020654, 2007.
20. Joo, Y.-H.; Gao, H.; Zhang, Y.; Shreeve, J. M. Inorg. Chem. 2010, 49, 3282
21. Kiyato, K.; Toshikazu, O.; Sunao, M.; Ryozo, O. Synthesis 1998, 6, 910
22. Deo, K.; Desai, S.; Rathod, D.; Parikh, C.; Mokal, R. An Improved Process for Preparing Losartan Potassium. WO/2010/029457 A2, 2010.
23. Charles, E. R.; Calvin, M. A. Anal. Chem. 1957, 29, 854
24. Zhongxi, Z. Z.; Qingxi, W.; Erie, W. T.; Xue-Zhi, Q.; Dominic, I. J. Pharm. Biomed. Anal. 1999, 20, 129